Retrospective Data Study of HCV [hepatitis C virus] Genotype 1 Patients in the UK [United Kingdom] Treated With ViraferonPeg [peginterferon alfa-2b] and Rebetol [ribavirin].
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2013
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 04 Jun 2010 Actual number of patients (442) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Feb 2009 as reported by ClinicalTrials.gov.